Physician profile
Eleazar E Soto
NPI 1568660355
$480.65
in general payments reported to CMS, 2019-2025
8 companies · $232 in 2025
The $232 reported for 2025 was more than what 84% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2021: $52.35 · 2024: $54.48 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $161.41 | 2025 | |
| Ge Healthcare | $141.57 | 2019 | |
| Biogen, INC. | $55.90 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $34.66 | 2024 | |
| Trevena, INC. | $31.72 | 2021 | |
| Hologic Sales and Service, LLC | $20.63 | 2021 | |
| Millicent US INC | $19.82 | 2024 | Femring, Intrarosa |
| Sumitomo Pharma America, INC. | $14.94 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eleazar Soto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.